Eva Tsakonas
About
In The Last Decade
Eva Tsakonas
9 papers receiving 428 citations
Peers
Comparison fields: 5 of 70
- Rheumatology 310
- Immunology 72
- Hematology 62
- Ophthalmology 53
- Radiology, Nuclear Medicine and Imaging 51
Countries citing papers authored by Eva Tsakonas
This map shows the geographic impact of Eva Tsakonas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Tsakonas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Tsakonas more than expected).
Fields of papers citing papers by Eva Tsakonas
This network shows the impact of papers produced by Eva Tsakonas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Tsakonas. The network helps show where Eva Tsakonas may publish in the future.
Co-authorship network of co-authors of Eva Tsakonas
This figure shows the co-authorship network connecting the top 25 collaborators of Eva Tsakonas. A scholar is included among the top collaborators of Eva Tsakonas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Tsakonas. Eva Tsakonas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 43 | |
| 2 | 6 | |
| 3 | Robot-assisted surgery compared with open surgery and laparoscopic surgery. | 9 |
| 4 | Robot-Assisted Surgery Compared with Open Surgery and Laparoscopic Surgery: Clinical Effectiveness and Economic Analyses | 49 |
| 5 | Vancomycin or Metronidazole for Treatment of Clostridium difficile Infection: Clinical and Economic Analyses | 11 |
| 6 | Table 16, Capital and Operating Costs of da Vinci Surgical System* | 1 |
| 7 | 0 | |
| 8 | 6 | |
| 9 | Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. | 124 |
| 10 | 205 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.